The Undertreatment of Gallbladder Cancer: Gaps in Seeking, Reaching, and Receiving Care Jessica M. KeilsonShishir K. Maithel Gastrointestinal Oncology 04 March 2021 Pages: 2925 - 2927
Underutilization of Lymphadenectomy for Gallbladder Cancer: A Persistent Problem with Dire Consequences Sameer H. Patel Hepatobiliary Tumors 06 March 2021 Pages: 2928 - 2930
Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases Daniel Brock HewittTimothy M. PawlikJordan M. Cloyd Hepatobiliary Tumors 21 January 2021 Pages: 2931 - 2933
Optimal Management of T1 Gastric Cancer: An Open Question Court ColinNakauchi MasayaStrong Vivian Gastrointestinal Oncology 01 February 2021 Pages: 2934 - 2935
Disparities in Gastric Cancer: Can we do better? Deepa MaggeMarcus Tan Gastrointestinal Oncology 24 March 2021 Pages: 2936 - 2938
The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions Audrey E. KamAshiq Masood Gastrointestinal Oncology 09 February 2021 Pages: 2939 - 2940
Patient-Reported Outcomes Measures in Abdominal Cancer Surgery and Student-Led Surgical Research Augusto LeónKlaus PuschelFrancisca Honold Global Health Services Research 31 March 2021 Pages: 2941 - 2943
Editorial: Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip Baran D. Sumer Head and Neck Oncology 09 February 2021 Pages: 2944 - 2945
Elucidating the Efficacy of Pancreatectomy for Renal Cell Metastases Remains Problematic Natasha LeighWilliam G. Hawkins Pancreatic Tumors 03 March 2021 Pages: 2946 - 2948
Undertreatment of Gallbladder Cancer: A Nationwide Analysis Marianna V. PapageorgeSusanna W. L. de GeusTeviah E. Sachs Hepatobiliary Tumors 10 February 2021 Pages: 2949 - 2957
ASO Author Reflections: Failing to Adhere to Treatment Guidelines in Gallbladder Cancer Marianna V. PapageorgeTeviah E. Sachs ASO Author Reflections 08 February 2021 Pages: 2958 - 2959
Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer Phillip M. Kemp BohanAnne E. O’SheaTimothy J. Vreeland Hepatobiliary Tumors 10 February 2021 Pages: 2960 - 2972
ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer Phillip M. Kemp BohanDaniel W. NelsonTimothy J. Vreeland ASO Author Reflections 09 February 2021 Pages: 2973 - 2974
Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy Ryota NakanishiEiji OkiMasaki Mori Hepatobiliary Tumors 16 January 2021 Pages: 2975 - 2985
ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis Ryota NakanishiEiji OkiMasaki Mori ASO Author Reflections 16 March 2021 Pages: 2986 - 2987
Liver Transection-First Approach in Hepatopancreatoduodenectomy for Hilar Cholangiocarcinoma: A Safe and Secure Technique for the Early Assessment of Curable Resection and Vascular Reconstruction Takamichi IshiiSatoru SeoKojiro Taura Hepatobiliary Tumors 09 November 2020 Pages: 2988 - 2989
Transfissural Approach for Laparoscopic Resection of a Deep Segment 8 Lesion in Contact with the Hepatocaval Confluence Satoshi OgisoSatoru SeoKojiro Taura Hepatobiliary Tumors 09 November 2020 Pages: 2990 - 2990
ASO Author Reflections: Making a Wide Window to the Hepatocaval Confluence for Laparoscopic Resection of a Deep Segment 8 Lesion Satoshi OgisoSatoru Seo ASO Author Reflections 03 January 2021 Pages: 2991 - 2991
Local Endoscopic Resection is Inferior to Gastrectomy for Early Clinical Stage T1a and T1b Gastric Adenocarcinoma: A Propensity-Matched Study Sivesh K. KamarajahSheraz R. MarkarFadi S. Dahdaleh Gastrointestinal Oncology 15 January 2021 Pages: 2992 - 2998
ASO Author Reflections: Endoscopic Resection or Gastrectomy for Early Clinical Stage T1a or T1b Gastric Adenocarcinoma Sivesh K. KamarajahSheraz R. MarkarAlexander W. Phillips ASO Author Reflections 21 January 2021 Pages: 2999 - 3000
Usefulness of Neutrophil to Lymphocyte Ratio at Recurrence for Predicting Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma Shota HoshinoMasashi TakeuchiYuko Kitagawa Thoracic Oncology 10 March 2021 Pages: 3001 - 3008
Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio Masashi TakeuchiShota HoshinoYuko Kitagawa ASO Author Reflections 02 March 2021 Pages: 3009 - 3010
Evolution of Esophagectomy for Cancer Over 30 Years: Changes in Presentation, Management and Outcomes S. Michael GriffinRhys JonesAlexander W. Phillips Thoracic Oncology Open access 18 October 2020 Pages: 3011 - 3022
ASO Author Reflections: 30 Years of Esophagectomy A. W. PhillipsS. K. KamarajahS. M. Griffin ASO Author Reflections Open access 18 March 2021 Pages: 3023 - 3024
Impact of Examined Lymph Node Count for Esophageal Squamous Cell Carcinoma in Patients who Underwent Right Transthoracic Esophagectomy Yu-Zhen ZhengXiao-Qiang LiJian-Hua Fu Thoracic Oncology 18 October 2020 Pages: 3025 - 3033
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy Roberta La MendolaMaria BencivengaSimone Giacopuzzi Thoracic Oncology Open access 19 October 2020 Pages: 3034 - 3043
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event Roberta La MendolaMaria BencivengaSimone Giacopuzzi ASO Author Reflections 11 November 2020 Pages: 3044 - 3045
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer Taichi MatsubaraShinkichi TakamoriTatsuro Okamoto Thoracic Oncology 21 October 2020 Pages: 3046 - 3054
ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC Taichi MatsubaraTatsuro Okamoto ASO Author Reflections 23 October 2020 Pages: 3055 - 3056
Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma Akifumi NakamuraNobuyuki KondoSeiki Hasegawa Thoracic Oncology 29 October 2020 Pages: 3057 - 3065
Resection of Parapharyngeal Space Tumors Located in the Prestyloid Compartment: Efficacy of the Cervical Approach Takashi MatsukiIsaku OkamotoKouki Miura Thoracic Oncology 03 November 2020 Pages: 3066 - 3072
ASO Author Reflections: What is the Best Surgical Approach for Benign Tumors Arising from the Prestyloid Compartment in the Parapharyngeal Space? Takashi Matsuki ASO Author Reflections 30 October 2020 Pages: 3073 - 3074
Multicenter Prospective Cohort Study of the Patient-Reported Outcome Measures PRO-CTCAE and CAT EORTC QLQ-C30 in Major Abdominal Cancer Surgery (PATRONUS): A Student-Initiated German Medical Audit (SIGMA) Study CHIR-Net SIGMA Study Group*André L. Mihaljevic Global Health Services Research Open access 08 March 2021 Pages: 3075 - 3089
ASO Author Reflections: The Magic of Clinical Research—The Student-Led PATRONUS Study Unveils Two Patient-Reported Outcome Measures for Use in Surgical Oncology The CHIR-Net SIGMA Study GroupAndré L. Mihaljevic ASO Author Reflections Open access 22 February 2021 Pages: 3090 - 3091
Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip Amanda E. YungMichael S. QueSydney Ch’ng Head and Neck Oncology 02 January 2021 Pages: 3092 - 3099
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma Giuseppe MalleoRoberto SalviaGiovanni Butturini Pancreatic Tumors Open access 11 February 2021 Pages: 3100 - 3108
ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma Giuseppe MalleoRoberto SalviaGiovanni Butturini ASO Author Reflections 09 February 2021 Pages: 3109 - 3110
Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology Elizabeth J. OleckiKelly A. StahlNiraj J. Gusani Pancreatic Tumors 31 January 2021 Pages: 3111 - 3122
ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients Elizabeth J. OleckiNiraj J. Gusani ASO Author Reflections 22 February 2021 Pages: 3123 - 3123
ASO Visual Abstract: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival in Those with Low-Risk Pathology Elizabeth J. OleckiKelly A. StahlNiraj J. Gusani ASO Visual Abstract 18 March 2021 Pages: 3124 - 3124
An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-CAR) Ryan K. SchmockerMichael J. WrightRichard A. Burkhart Pancreatic Tumors 13 October 2020 Pages: 3125 - 3134
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma Takuro YamaguchiKenichiro UemuraTaijiro Sueda Pancreatic Tumors 30 October 2020 Pages: 3135 - 3144
ASO Author Reflections: Clinical Implications of Circulating Tumor DNA in Pancreatic Cancer Patients Takuro YamaguchiKenichiro UemuraShinya Takahashi ASO Author Reflections 03 January 2021 Pages: 3145 - 3146
The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality Barbara Aldana BlancoMichael PoulsonTeviah E. Sachs Pancreatic Tumors 01 November 2020 Pages: 3147 - 3155
ASO Author Reflections: The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality Michael R. PoulsonBarbara Aldana BlancoTeviah E. Sachs ASO Author Reflections 25 October 2020 Pages: 3156 - 3156
Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I–II Pancreatic Adenocarcinoma Douglas S. SwordsCourtney L. Scaife Pancreatic Tumors 03 November 2020 Pages: 3157 - 3168
ASO Author Reflections: Using Causal Mediation Analysis to Understand the Proportion of Survival Disparities Mediated by Potentially Modifiable Treatment Factors Douglas S. SwordsCourtney L. Scaife ASO Author Reflections 09 November 2020 Pages: 3169 - 3170
The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis Piera LeonFabio GiannoneFabrizio Panaro Pancreatic Tumors 06 November 2020 Pages: 3171 - 3183
ASO Author Reflections: Exploring the Oncologic Impact of Pancreatic Fistula after Distal Pancreatectomy for Ductal Adenocarcinoma Piera LeonFabrizio Panaro ASO Author Reflections 21 November 2020 Pages: 3184 - 3185
Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis Wilson Luiz da Costa Jr.Hop S. Tran CaoNader N. Massarweh Pancreatic Tumors 10 November 2020 Pages: 3186 - 3195
